Tianli Pharma net profit soars in H1 2024

Shandong Tianli Pharmaceutical Co., Ltd. (Tianli Pharma) boasted gross assets of USD340.88 million (RMB2.43 billion) during the first half of 2024, with net assets reaching USD219.79 million (RMB1.57 billion), a revenue of USD231.03 million (RMB1.65 ...

Sorbitol China News 202408

www.cnchemicals.com